Kala Pharmaceuticals Inc (KALA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.38
• Market Cap: $373.83M
• EPS: $-5.64
• 52-Week High: $20.60
• 52-Week Low: $0.35

About Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc, based in Watertown, Massachusetts, is a forward-thinking biopharmaceutical company focused on the discovery, development, and commercialization of cutting-edge therapies for ocular conditions. Leveraging its proprietary nanoparticle-based mucus penetrating particle (MPP) technology, Kala aims to significantly enhance drug delivery and therapeutic effectiveness in ophthalmic care. By prioritizing innovative solutions for eye diseases, the company is strategically posi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Kala Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does KALA pay dividends?

Kala Pharmaceuticals Inc (KALA) does not currently pay a regular dividend.

What is KALA's market cap?

Kala Pharmaceuticals Inc (KALA) has a market capitalization of $373.83M with a current stock price of $0.38.